Long-read discovery in cancer cell lines defines a cis-spliced fusion RNA panel and its clinical associations across TCGA.
This study defines cis-spliced fusion RNAs as a previously underappreciated class of cancer-associated transcript alterations, linked here to driver-associated molecular programs, pathologic stage, and survival across a screening universe wider than the 461-candidate long-read panel.